Diffusion Pharmaceuticals (DFFN) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 59 252 sessions, October 17, 2022 to October 17, 2023
- Largest daily move
- -22.5% close of August 18, 2023
- 1-year change
- +4.2% closing prices, October 17, 2022 to October 17, 2023
Company Description
Diffusion Pharmaceuticals (Nasdaq: DFFN) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $9.0M.
DFFN has gained 4.2% over the past year. The last closing price was $8.67.
This page collects what Stock Titan holds for DFFN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Diffusion Pharmaceuticals (DFFN) closed at $8.67 on October 17, 2023. Over the past 12 months, the price has gained 4.2%.
DFFN Metrics & Rankings
Price returns through October 17, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Diffusion Pharmaceuticals has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, earnings, clinical trial. View all DFFN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
DFFN Company Profile & Sector Positioning
Diffusion Pharmaceuticals (DFFN) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing DFFN often look at related companies in the same sector, including IMV (IMV), IN8bio, Inc. (INAB), Kiora Pharmaceuticals, Inc. (KPRX), Calidi Biotherapeutics, Inc. (CLDI), and Genprex, Inc. (GNPX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DFFN's relative position within its industry.